Senate
File
2337
S-5015
Amend
Senate
File
2337
as
follows:
1
1.
By
striking
everything
after
the
enacting
clause
and
2
inserting:
3
<
Section
1.
Section
686B.3,
subsection
2,
Code
2020,
is
4
amended
to
read
as
follows:
5
2.
A
plaintiff
in
an
asbestos
action,
including
an
action
6
alleging
a
nonmalignant
or
a
malignant
condition,
or
a
silica
7
action
involving
silicosis,
shall
include
with
the
detailed
8
narrative
medical
report
file
with
the
petition
or
other
9
initial
pleading
a
sworn
information
form
containing
specifying
10
the
evidence
that
provides
the
basis
for
each
claim
against
11
each
defendant.
The
sworn
information
form
shall
include
all
12
of
the
following
with
specificity
:
13
a.
The
name,
address,
date
of
birth,
social
security
number,
14
marital
status,
occupation,
current
and
past
worksites,
and
15
employer
of
the
exposed
person
,
and
any
person
through
whom
the
16
exposed
person
alleges
exposure
.
17
b.
The
plaintiff’s
relationship
to
the
exposed
person
or
18
person
through
whom
the
exposure
is
alleged.
19
b.
Each
person
through
whom
the
exposed
person
was
exposed
20
to
asbestos
or
silica,
and
the
exposed
person’s
relationship
21
to
each
person.
22
c.
Each
asbestos-containing
product
or
silica
product,
23
whether
from
a
bankrupt
entity
or
otherwise,
to
which
the
24
exposed
person
was
exposed,
or
if
the
exposed
person
was
25
exposed
through
another
person,
to
which
that
person
was
26
exposed.
27
c.
d.
The
specific
location
and
manner
of
each
alleged
28
exposure,
including
the
specific
location
and
manner
of
29
exposure
for
any
person
through
whom
the
exposed
person
alleges
30
exposure
was
exposed
to
asbestos
or
silica
.
31
d.
e.
The
beginning
and
ending
dates
of
each
alleged
32
exposure
and
the
frequency
of
the
exposure
of
the
exposed
33
person
to
the
product
or
its
use,
including
for
any
person
34
through
whom
the
exposed
person
was
exposed
.
35
-1-
SF2337.3247
(2)
88
(amending
this
SF
2337
to
CONFORM
to
HF
2501)
ko/jh
1/
2
#1.
e.
f.
The
identity
of
the
manufacturer
or
seller
of
the
1
specific
asbestos
or
silica
product
for
each
exposure.
2
f.
The
identity
of
the
defendant
or
defendants
against
whom
3
the
plaintiff
asserts
a
claim.
4
g.
The
specific
asbestos-related
or
silica-related
disease
5
claimed
to
exist.
6
h.
Any
supporting
documentation
relating
to
the
information
7
required
under
this
subsection.
8
Sec.
2.
Section
686B.3,
subsection
3,
Code
2020,
is
amended
9
by
striking
the
subsection.
10
Sec.
3.
Section
686B.3,
subsection
5,
Code
2020,
is
amended
11
to
read
as
follows:
12
5.
The
court
shall
dismiss
the
asbestos
action
or
silica
13
action
without
prejudice
on
finding
that
the
plaintiff
has
14
failed
to
make
the
prima
facie
showing
required
by
this
chapter
15
or
failed
to
comply
with
the
requirements
of
this
section
16
subsections
1
and
2
.
The
court
shall
dismiss
the
asbestos
17
action
or
silica
action
without
prejudice
as
to
any
defendant
18
whose
product
or
premises
is
not
identified
in
the
information
19
required
pursuant
to
subsection
2.
20
Sec.
4.
APPLICABILITY.
This
Act
applies
to
an
asbestos
21
action,
including
an
action
alleging
a
nonmalignant
or
22
malignant
condition,
or
a
silica
action
involving
silicosis
23
filed
on
or
after
July
1,
2020.
>
24
______________________________
ZACH
NUNN
-2-
SF2337.3247
(2)
88
(amending
this
SF
2337
to
CONFORM
to
HF
2501)
ko/jh
2/
2